Akineton and blood creatine phosphokinase increased 
Akineton and blood creatine phosphokinase increased Patient Reports February 11, 2012
Akineton Side Effects Report #5650536-0
Akineton side effect was reported by a Consumer or non-health professional from JAPAN on Feb 25, 2008. Female patient, 72 years of age, weighting 88.18 lb, was diagnosed with depression
and was treated with Akineton. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, dehydration, hepatic function abnormal, labile blood pressure, nausea , neuroleptic malignant syndrome. Akineton dosage: 3 MG/DAY. During the same period patient was treated with BLOPRESS, MEVALOTIN, UBRETID, DEPAS, MAGNESIUM OXIDE, ANAFRANIL, SERENACE, LUDIOMIL. Patient was hospitalized. Patient recovered.Akineton Side Effects Report #5889646-1
Akineton side effect was reported by a Consumer or non-health professional from ITALY on May 16, 2008. Female patient, 64 years of age, was diagnosed with confusional state, alcohol detoxification, bipolar disorder
and was treated with Akineton. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, confusional state, hypernatraemia, metabolic acidosis, neuroleptic malignant syndrome, pyrexia. Akineton dosage: unknown. During the same period patient was treated with HALOPERIDOL, DISULFIRAM, CLOTIAPINE, LORAZEPAM, LITHIUM CARBONATE, VENLAFAXINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Akineton Side Effects Report #6083603-0
Akineton side effect was reported by a Consumer or non-health professional from ITALY on Feb 02, 2009. Female patient, 64 years of age, was diagnosed with confusional state, alcohol detoxification, bipolar disorder
and was treated with Akineton. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, confusional state, hypernatraemia, metabolic acidosis, neuroleptic malignant syndrome, pyrexia. Akineton dosage: unknown. During the same period patient was treated with HALOPERIDOL, ANTABUSE, ETUMINA, ORFIDAL, LITHIUM CARBONATE, VENLAFAXINE. Patient was hospitalized. Patient recovered.